For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Speaking for the nurses
+Columns
Speaking for the nurses
Friday 28 June 2019, 03:02 PM

Primary care researcher and practice nurse Barbara Docherty responds to the NZNO regarding the union’s pay deal for nurses last year
For NZNO to dismiss this as anger from only “the vocal minority” seems to me to be endorsing what these nurses were actually saying about not being he
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.